回复：安德里亚·勒尔、阿里夫·侯赛因、阿卡什·帕奈克等人。转移性去势抵抗性前列腺癌患者接受鲁卡帕尼治疗后BRCA回复突变的出现。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2022.09.010 。 - Suppr

Re: Andrea Loehr, Arif Hussain, Akash Patnaik, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.010.

作者信息

Qi Feng, Xu Zicheng, Zou Qing

机构信息

Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.

出版信息

Eur Urol. 2023 Mar;83(3):e76-e77. doi: 10.1016/j.eururo.2022.12.024. Epub 2023 Jan 3.

DOI:10.1016/j.eururo.2022.12.024

PMID:36604272

Abstract

摘要

相似文献

Re: Andrea Loehr, Arif Hussain, Akash Patnaik, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.010.回复：安德里亚·勒尔、阿里夫·侯赛因、阿卡什·帕奈克等人。转移性去势抵抗性前列腺癌患者接受鲁卡帕尼治疗后BRCA回复突变的出现。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2022.09.010 。

Eur Urol. 2023 Mar;83(3):e76-e77. doi: 10.1016/j.eururo.2022.12.024. Epub 2023 Jan 3.

Reply to Feng Qi, Zicheng Xu, and Qing Zou's Letter to the Editor re: Andrea Loehr, Arif Hussain, Akash Patnaik, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.010.回复冯琦、徐子成和邹清致编辑的信，信的内容关于：安德里亚·勒尔、阿里夫·侯赛因、阿卡什·帕奈克等人。鲁卡帕尼治疗后转移性去势抵抗性前列腺癌患者中BRCA回复突变的出现。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2022.09.010 。

Eur Urol. 2023 Mar;83(3):e78. doi: 10.1016/j.eururo.2022.12.023. Epub 2023 Jan 7.

Reply to Johann S. de Bono, Maha Hussain, and Jinyu Kang's Letter to the Editor re: Konrad H. Stopsack. Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024.回复约翰·S·德博诺、玛哈·侯赛因和金宇康致编辑的信：关于康拉德·H·斯托普萨克。PARP抑制在转移性去势抵抗性前列腺癌中的疗效与非BRCA DNA修复改变差异很大：从奥拉帕利3期PROfound试验中重建队列B的预设终点。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2020.09.024

Eur Urol. 2021 Mar;79(3):e81-e82. doi: 10.1016/j.eururo.2020.12.018. Epub 2020 Dec 23.

Re: Konrad H. Stopsack. Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024.回复：康拉德·H·斯托普萨克。聚（ADP-核糖）聚合酶（PARP）抑制剂在转移性去势抵抗性前列腺癌中的疗效在非BRCA DNA修复改变的情况下差异很大：从奥拉帕利的3期PROfound试验中重建队列B的预先设定终点。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2020.09.024

Eur Urol. 2021 Mar;79(3):e83-e84. doi: 10.1016/j.eururo.2020.12.016. Epub 2020 Dec 23.

Re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032: Interpreting the Effect of Ipilimumab Following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer.回复：卡里姆·菲扎齐、查尔斯·G·德雷克、托马什·M·比尔等人。多西他赛后转移性去势抵抗性前列腺癌放疗后伊匹木单抗与安慰剂对比的III期试验最终分析确定了长期存活者过多。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2020.07.032：解读伊匹木单抗对多西他赛后转移性去势抵抗性前列腺癌患者放疗后的疗效

Eur Urol. 2021 Jan;79(1):e10-e11. doi: 10.1016/j.eururo.2020.09.049. Epub 2020 Oct 24.

Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033.回复：约翰·S·德博诺、马修·R·史密斯、弗雷德·萨德等。醋酸阿比特龙治疗转移性去势抵抗性前列腺癌患者后的后续化疗及治疗模式：COU-AA-302的事后分析。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2016.06.033

Eur Urol. 2017 Feb;71(2):e55. doi: 10.1016/j.eururo.2016.08.010. Epub 2016 Aug 16.

Eur Urol. 2017 Jan;71(1):e9-e10. doi: 10.1016/j.eururo.2016.10.006. Epub 2016 Oct 13.

Reply to Robert J. van Soest and Ronald de Wit's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033.对罗伯特·J·范·索斯特和罗纳德·德·威特致编辑的信的回复，信的主题为：约翰·S·德博诺、马修·R·史密斯、弗雷德·萨德等人。醋酸阿比特龙治疗转移性去势抵抗性前列腺癌患者后的后续化疗及治疗模式：COU - AA - 302的事后分析。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2016.06.033 。

Eur Urol. 2017 Jan;71(1):e11. doi: 10.1016/j.eururo.2016.10.005. Epub 2016 Oct 14.

Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib.在使用鲁卡帕尼治疗转移性去势抵抗性前列腺癌后，患者出现 BRCA 回复突变。

Eur Urol. 2023 Mar;83(3):200-209. doi: 10.1016/j.eururo.2022.09.010. Epub 2022 Oct 13.

Reply to Giandomenico Roviello, Daniele Generali, and Roberto Petrioli's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033.对吉安多梅尼科·罗维耶洛、达尼埃莱·热纳拉利和罗伯托·彼得廖利致编辑的信的回复，信的主题为：约翰·S·德博诺、马修·R·史密斯、弗雷德·萨德等人。醋酸阿比特龙治疗转移性去势抵抗性前列腺癌患者后的后续化疗及治疗模式：COU - AA - 302的事后分析。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2016.06.033 。

Eur Urol. 2017 Feb;71(2):e56. doi: 10.1016/j.eururo.2016.08.011. Epub 2016 Aug 17.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Andrea Loehr, Arif Hussain, Akash Patnaik, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.010.

作者信息

机构信息

出版信息

相似文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献